Estimated Incidence of Hepatitis A Virus Infection in Catalonia

Annals of Epidemiology

Volumn 16, Issue 11, 2006, Pages 812-819

  Oviedo, Manuel ^a   Muñoz, M Pilar ^a   Domínguez, Angela ^a   Carmona, Gloria ^a  

^a Generalitat of Catalonia   (Spain)

Author keywords

Hepatitis A; Incidence; Infection; Prevalence; Statutory Reporting

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CLINICAL FEATURE; CONFIDENCE INTERVAL; FEMALE; HEALTH SURVEY; HEPATITIS A; HUMAN; INCIDENCE; INFECTION RATE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SPAIN;

ADOLESCENT; ADULT; AGE FACTORS; BIOMETRY; CHILD; CHILD, PRESCHOOL; DISEASE NOTIFICATION; HEPATITIS A; HUMANS; INCIDENCE; INFANT; MIDDLE AGED; SPAIN;

EID: 33751208325     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annepidem.2006.02.005     Document Type: Article

References (52)

1. th ed (2005), Elsevier, Philadelphia 2162-2185
2. th ed (2004), Wiley, Chichester, NY 199-247
3. Altman C., Molinie C., Soudiere S., Denee J.M., Buisson Y., and Buffet C. Viral hepatitis A with prolonged course in adults. Gastroenterol Clin Biol 20 (1996) 42-46
4. Crowcroft N.S., Walsh B., Davison K.L., Gungabissoon U., and for the PHLS Advisory Committee on Vaccination and Immunisation. Guidelines for the control of hepatitis A virus infection. Commun Dis Public Health 4 (2001) 213-227
5. Nygard K., Andersson Y., Lindkvist P., Ancker C., Asteberg I., Danneturn E., et al. Imported rocket salad partly responsible for increased incidence of hepatitis A cases in Sweden, 2000-2001. Eurosurveillance 6 (2001) 151-153
6. Staess C.J., Schlenker T.L., Risk I., Cannon K.G., Harris H., Pavia A.T., et al. Sources of infection among persons with acute hepatitis A and no identified risk factors during a sustained community-wide outbreak. Pediatrics 106 (2000). http://www.pediatrics.org/cgi/content/full/106/4/e54 Available at:
7. Shapiro C.N., Coleman P.J., McQuillan G.M., Alter M.J., and Margolis H.S. Epidemiology and risk group in the USA. Vaccine 10 Suppl 1 (1992) S59-S62
8. Bell A., Ncube F., Hansell A., Davison K.L., Young Y., Gilson R., et al. An outbreak of hepatitis A among young men associated with having sex in public venues. Commun Dis Public Health 4 (2001) 163-170
9. Kyrlagkitsis I., Cramp M.E., Smith H., Portmann B., and O'Grady J. Acute hepatitis A virus infection: A review of prognostic factors from 25 years experience in a tertiary referral center. Hepatogastroenterology 49 (2002) 524-528
10. Couturier E., Delarocque-Astagneau E., Vaillant V., and Desenclos J.-C. Surveillance de l'hepatitis A en France au cours des vingt dernières années: les donnes actuelles ne permettent pas d'estimer la vaux d'incidence. Bul Epidemiol Hebdomadaire 5 (2005) 17-18
11. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 48 (1999) 1-37
12. Delarocque-Astagneau E., Cordeiro E., Vaillant V., and Valenciano M. Evaluation d'un systeme pilote de surveillance pour l'hepatite A, France 2001. Bull Epidemiol Hebdomadaire 5 (2005) 19-20
13. Morris M.C., Gay N.J., Hesketh L.M., Morgan-Capner P., and Miller E. The changing epidemiological pattern of hepatitis A in England and Wales. Epidemiol Infect 128 (2002) 457-463
14. ElSaadany S., Gully P., and Giulivi A. Hepatitis A, B, and C in Canada. Results from the National Sentinel Health Unit Surveillance System, 1993-1995. Can J Public Health 93 (2002) 435-438
15. Dominguez A., Bruguera M., Plans P., Costa J., and Salleras L. Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization. J Med Virol 73 (2004) 172-176
16. Morris-Cunnington M.C., Edmunds W.J., Miller E., and Brown D.W. A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales. Am J Epidemiol 15 (2004) 786-794
17. Koff R.S. Seroepidemiology of hepatitis A in the United States. J Infect Dis 71 Suppl 1 (1995) S19-S23
18. Gay N.J., Morgan-Capner P., Wright J., Farrington C.P., and Miller E. Age-specific antibody prevalence to hepatitis A in England: Implications for disease control. Epidemiol Infect 113 (1994) 113-120
19. Moschen M.E., Floreani A., Zamparo E., Baldo V., Majori S., Gasparini V., et al. Hepatitis A infection: A seroepidemiological study in young adults in North-East Italy. Eur J Epidemiol 13 (1997) 875-878
20. Thierfelder W., Hellenbrand W., Meisel H., Schreier E., and Dortschy R. Prevalence of markers for hepatitis A, B and C in the German population. Results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol 17 (2001) 429-435
21. Fix A.D., Martin O.S., Gallicchio L., Vial P.A., and Lagos R. Age-specific prevalence of antibodies to hepatitis A in Santiago, Chile: Risk factors and shift in age of infection among children and young adults. Am J Trop Med Hyg 66 (2002) 628-632
22. Keiding N. Incidence-prevalence relationships. In: Armitage P., and Colton T. (Eds). Encyclopedia of Biostatistics (1998), Wiley, Chichester, NY 2004-2007
23. Grenfell B.T., and Anderson R.M. The estimation of age-related rates of infection from case notifications and serological data. J Hyg (Lond) 95 (1985) 419-436
24. Struchiner C.J., de Almeida L.M., de Azevedo R.S., and Massad E. Hepatitis A incidence rate estimates from a pilot seroprevalence survey in Rio de Janeiro, Brazil. Int J Epidemiol 28 (1999) 776-781
25. Bruguera M., Salleras L., Plans P., Vidal J., Navas E., Domínguez A., et al. Cambios en la seroepidemiologia de la infección por el virus de la hepatitis A en Cataluña en el periodo 1989-1996. Implicaciones para una nueva estratégia vacunal. Med Clin (Barc) 112 (1999) 406-408
26. Department of Health. Salut a la població de Catalunya (2004), Generalitat de Catalunya, Barcelona
27. Anuari estadístic 2003 (2003), Generalitat de Catalunya, Institut d'Estadística de Catalunya, Barcelona
28. Armstrong G.L., and Bell B.P. Hepatitis A virus infection in the United States: Model-based estimates and implications for childhood immunization. Pediatrics 109 (2002) 839-845
29. Farrington C.P. Modelling forces of infection for measles, mumps and rubella. Stat Med 9 (1990) 953-967
30. Muñoz M.P., Dominguez A., and Salleras L. Estimated varicella incidence on the basis of a seroprevalence survey. Epidemiol Infect 127 (2001) 501-507
31. Ikematsu H., Kashiwagi S., Hayashi J., Nomura H., Kajiyama W., Tani S., et al. A seroepidemiologic study of hepatitis A virus infections: Statistical analysis of two independent cross-sectional surveys in Okinawa, Japan. Am J Epidemiol 126 (1987) 50-54
32. Ades A.E., and Nokes D.J. Modeling age- and time-specific incidence from seroprevalence: Toxoplasmosis. Am J Epidemiol 137 (1993) 1022-1034
33. Farrington C.P., and Kanaan M.N. Estimation of the basic reproduction number for infectious diseases from age-stratified serological survey data. Appl Stat 50 Part 3 (2001) 251-292
34. Keiding N. Age-specific incidence and prevalence: A statistical perspective. J R Stat Soc A 154 (1991) 371-412
35. Bruguera M. Hepatitis (1993), Doyma, Barcelona
36. Efron B., and Tibshirani R.J. An Introduction to the Bootstrap (1993), Chapman & Hall, San Francisco, CA
37. Davison A.C., and Hinkley D.V. Bootstrap Methods and Their Application (1997), Cambridge University Press, Cambridge, MA
38. Venables W.N., and Ripley B.D. Modern Applied Statistics With S. 4th ed (2002), Springer, Oxford, NY 133-138
39. Dominguez A., Salleras L., Carmona G., and Batalla J. Effectiveness of a mass hepatitis A vaccination programme in preadolescents. Vaccine 21 (2003) 698-701
40. Alter M.J., Mares A., Hadler S.C., and Maynard J.E. The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis. Am J Epidemiol 125 (1987) 133-139
41. Anonim. Resum de les malalties de declaració obligatoria a Catalunya durant l'any 2003. Bull Epidemiol Catalunya XXV (2004) 175-185
42. Domínguez A., Torner N., and Carmona G. Hepatitis A. Hay brotes en nuestro medio?. In: Campins M., and Moraga F. (Eds). Vacunas. 2005 (2005), Prous Science, Barcelona 25-36
43. Honish L., and Bergstrom K. Hepatitis A infected food handler at an Edmonton, Alberta retail food facility: Public health protection strategies. Can Commun Dis Rep 27 (2001) 177-180
44. Maguire H.C., Handford S., Perry K.R., Nicholas S., Waight P., Parry J.V., et al. A collaborative case control study of sporadic hepatitis A in England. Commun Dis Rep CDR Rev 5 (1995) R33-R40
45. Termorshuizen F., Dorigo-Zetsma J.W., de Melker H.E., van den Hof S., and Conyn-Van Spaendonck M.A. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: A population-based survey. Epidemiol Infect 124 (2000) 459-466
46. Averhoff F., Shapiro C.N., Bell B.P., Hyams I., Burd L., Deladisma A., et al. Control of hepatitis A through routine vaccination of children. JAMA 286 (2001) 2968-2973
47. Samandari T., Bell B.P., and Armstrong G.L. Quantifying the impact of hepatitis A immunization in the United States, 1995-2001. Vaccine 22 (2004) 4342-4350
48. Pebody R.G., Leino T., Ruutu P., Kinnunen L., Davidkin I., Nohynek H., et al. Foodborne outbreaks of hepatitis A in a low endemic country: An emerging problem?. Epidemiol Infect 120 (1998) 55-59
49. Diel R., and Schneider S. Transmission of hepatitis A in Hamburg, Germany, 1998-1999-A prospective population based study. Eur J Epidemiol 17 (2001) 175-182
50. In: Heymann D.L. (Ed). Control of Communicable Diseases Manual. 18th ed (2004), American Public Health Association, Washington, DC
51. Sadetzki S., Rostmi N., and Modan B. Hepatitis A outbreak originating in a day care center: A community case report. Eur J Epidemiol 15 (1999) 549-551
52. Flahault A., Maison P., Farran N., and Massari V. Six years surveillance of hepatitis A and B in general practice in France. Eurosurveillance 2 (1997) 56-57